Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.

Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.

Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million. As ...

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) ...

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

UCB has announced positive new three-year data for its inflammatory disease drug Bimzelx (bimekizumab) in adults with active ...

Bimekizumab showed sustained symptom improvement and consistent safety in patients with psoriatic arthritis, including ...

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

From joint pain and cold weather to diet and exercise, doctors debunk 10 persistent myths about arthritis causes, treatment ...

Psoriatic arthritis (PsA) is an autoimmune disease ... it is important for research to prove the effectiveness of any treatment before people decide to take it. Although there’s a lot of ...

When I was first diagnosed with psoriatic arthritis, my rheumatologist told me that without treatment I would not live to see 50. I was 35 when he told me that and I did not appreciate his scare ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...